Homoharringtonine and granulocyte colony-stimulating factor priming for acute myeloid leukemia: is it ready for prime time?

Abstract

Dr. Chen and colleagues presented their results with a homoharringtonine combination in treating relapsed refractory acute myeloid leukemia (AML). We reviewed the literature on homoharringtonine combinations in AML and suggest that randomized studies, especially with granulocyte colony-stimulating factor priming, be considered. L eu k L ym ph om a D ow nl… (More)
DOI: 10.3109/10428194.2013.776169

Topics

1 Figure or Table

Slides referencing similar topics